Nano Holdings, Inc. (FRA:3NQ)

Germany · Delayed Price · Currency is EUR

0.4320

-0.0060 (-1.37%)

Last updated: Oct 23, 2026, 9:00 PM CEST

Market Cap	39.77M -41.6%
Revenue (ttm)	1.09M +75.7%
Net Income	-5.51M
EPS	-0.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,040
Open	0.4240
Previous Close	0.4380
Day's Range	0.4240 - 0.4380
52-Week Range	0.3940 - 0.9850
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Nano Holdings

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company’s pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato,... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1996

Employees 23

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 3NQ

Financial Performance

In fiscal year 2026, Nano Holdings's revenue was 174.00 million, an increase of 61.11% compared to the previous year's 108.00 million. Losses were -943.00 million, 12.9% more than in 2025.

Financial numbers in JPY Financial Statements